These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21750485)

  • 1. Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study.
    Imberti R; Pietrobono L; Klersy C; Gamba G; Iotti GA; Cornara G
    Minerva Anestesiol; 2012 Feb; 78(2):168-75. PubMed ID: 21750485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
    Mayer SA; Brun NC; Broderick J; Davis SM; Diringer MN; Skolnick BE; Steiner T;
    Neurocrit Care; 2006; 4(3):206-14. PubMed ID: 16757825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa plus surgery for intracerebral hemorrhage.
    Sutherland CS; Hill MD; Kaufmann AM; Silvaggio JA; Demchuk AM; Sutherland GR
    Can J Neurol Sci; 2008 Nov; 35(5):567-72. PubMed ID: 19235439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous intracerebral hematoma: can we move beyond clot's removal?
    Stocchetti N
    Minerva Anestesiol; 2012 Feb; 78(2):142-3. PubMed ID: 22293919
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial.
    Al-Ajlan FS; Gladstone DJ; Song D; Thorpe KE; Swartz RH; Butcher KS; Del Campo M; Dowlatshahi D; Gensicke H; Lee GJ; Flaherty ML; Hill MD; Aviv RI; Demchuk AM;
    Stroke; 2023 Mar; 54(3):715-721. PubMed ID: 36756899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).
    Steiner T; Vincent C; Morris S; Davis S; Vallejo-Torres L; Christensen MC
    J Stroke Cerebrovasc Dis; 2011; 20(4):287-94. PubMed ID: 20452785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
    Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
    JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.
    Narayan RK; Maas AI; Marshall LF; Servadei F; Skolnick BE; Tillinger MN;
    Neurosurgery; 2008 Apr; 62(4):776-86; discussion 786-8. PubMed ID: 18496183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
    Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
    Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative CT and cone-beam CT imaging for minimally invasive evacuation of spontaneous intracerebral hemorrhage.
    Hecht N; Czabanka M; Kendlbacher P; Raff JH; Bohner G; Vajkoczy P
    Acta Neurochir (Wien); 2020 Dec; 162(12):3167-3177. PubMed ID: 32193726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma].
    Rinkel GJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1827-9. PubMed ID: 16128178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hemostatic therapy using recombinant factor VIIa in a collagenase-induced intracerebral hemorrhage model in rats.
    Kawai N; Nakamura T; Nagao S
    Acta Neurochir Suppl; 2006; 96():212-7. PubMed ID: 16671457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours.
    Hallevi H; Gonzales NR; Barreto AD; Martin-Schild S; Albright KC; Noser EA; Illoh K; Khaja AM; Allison T; Escobar MA; Shaltoni HM; Grotta JC
    Stroke; 2008 Feb; 39(2):473-5. PubMed ID: 18174476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
    Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
    J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.